Latest Posts
About This Stock
More About This Stock
Read
Read
Read
Buy Jounce For A Bounce
Article By:
Quad 7 Capital
Friday, May 18, 2018 11:45 AM EDT
Jounce Therapeutics announced it will present data at the ASCO conference for its candidate JTX-2011, and the Street interpreted the abstract negatively. We see this selloff as an overreaction, and one we can take a gamble on.
4 Small Cap Biotechs With Upcoming Catalysts
Article By:
Scott Matusow
Wednesday, January 10, 2018 7:20 PM EDT
The biotech “run-up” trade has always attracted a wide array of traders looking to take advantage of potentially high alpha price moves before the actual catalyst/binary event come to fruition.
Cool Tech IPOs Finally Emerge After Drought
Article By:
Jon Markman
Tuesday, February 21, 2017 2:17 PM EDT
It has become a cliché. If your business is not scarfing up new technology, it’s being devoured by it. Given the choice, companies are choosing to eat... with more than $3.6 trillion in deals announced,